Loading...

FITC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2
C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
  • 17A2
    C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100203 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100204 500 µg 115€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Harel M, et al. 2020. J Immunol. 205:1167. PubMed
  2. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  3. Pei J, et al. 2022. J Virol. 96:e0194221. PubMed
  4. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  5. Meng J, et al. 2022. Cell Rep. 38:110492. PubMed
  6. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  7. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  8. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  9. Wu J, et al. 2023. Bioact Mater. 20:259. PubMed
  10. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  11. Brigo N, et al. 2022. Bio Protoc. 12:e4440. PubMed
  12. Hong Y, et al. 2022. J Leukoc Biol. 112:425. PubMed
  13. Mugarza E, et al. 2022. Sci Adv. 8:eabm8780. PubMed
  14. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  15. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  16. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  17. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  18. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  19. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  20. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  21. Kim HI, et al. 2022. Molecules. 27: . PubMed
  22. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  23. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  24. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  25. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  26. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  27. Peng Q, et al. 2023. EMBO Rep. 24:e56034. PubMed
  28. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  29. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  30. Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed
  31. Gon Y, et al. 2023. PLoS One. 18:e0279389. PubMed
  32. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  33. Zhang W, et al. 2022. Dev Cell. 57:329. PubMed
  34. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  35. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  36. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  37. Peng J, et al. 2023. Am J Reprod Immunol. 89:e13678. PubMed
  38. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  39. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  40. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  41. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  42. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  43. Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed
  44. Sambandam A, et al. 2023. Heliyon. 9:e14238. PubMed
  45. Masle-Farquhar E, et al. 2023. Front Immunol. 14:1095257. PubMed
  46. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  47. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  48. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  49. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  50. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  51. Kuang C, et al. 2023. Nat Commun. 14:2093. PubMed
  52. Zuo B, et al. 2023. Clin Transl Oncol. . PubMed
  53. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  54. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  55. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  56. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  57. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  58. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  59. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  60. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  61. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  62. Lee JH, et al. 2022. EBioMedicine. 77:103903. PubMed
  63. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  64. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  65. Dai L, et al. 2020. Cell. 182(3):722-733.e11. PubMed
  66. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  67. Zaman R, et al. 2021. Immunity. :. PubMed
  68. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  69. Zhang H, et al. 2021. Front Immunol. 12:644520. PubMed
  70. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  71. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  72. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  73. Gawish R, et al. 2022. Elife. 11:. PubMed
  74. Qiao Y, et al. 2021. Oncoimmunology. 10:1947569. PubMed
  75. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  76. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  77. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  78. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  79. Ford K, et al. 2020. Cancer Res. 80:1846. PubMed
  80. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  81. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  82. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  83. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  84. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  85. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  86. Wu X, et al. 2012. Biochem Pharmacol. 84:1164. PubMed
  87. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  88. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  89. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  90. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  91. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  92. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  93. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  94. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  95. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  96. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  97. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  98. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  99. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  100. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  101. Bromley SK, et al. 2020. Cell Reports. 32(9):108085. PubMed
  102. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  103. Diao L, et al. 2022. iScience. 25:105511. PubMed
  104. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  105. Huang Y, et al. 2021. Radiother Oncol. 162:34. PubMed
  106. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  107. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  108. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  109. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  110. Liu Q, et al. 2021. Cell Death Dis. 12:240. PubMed
  111. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  112. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  113. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  114. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  115. Mostafavi H, et al. 2022. PLoS Pathog. 18:e1010185. PubMed
  116. Sala D, et al. 2022. Mol Ther Methods Clin Dev. 25:170. PubMed
  117. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  118. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  119. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  120. Lesmeister M, et al. 2005. Reprod Biol Endocrinol. 29:74. PubMed
  121. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  122. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  123. Deng P, et al. 2022. Cells. 11:. PubMed
  124. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  125. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  126. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  127. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  128. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  129. White C, et al. 2014. J Immunol. 193:5933. PubMed
  130. Chen Y, et al. 2012. PLoS One. 7:e47190. PubMed
  131. Solanki A, et al. 2018. Development. 145. PubMed
  132. Shields BD, et al. 2019. Cancer Res. 79:1113. PubMed
  133. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  134. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  135. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  136. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  137. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  138. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  139. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  140. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  141. Carr RM, et al. 2021. Nat Commun. 12:2901. PubMed
  142. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  143. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  144. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  145. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  146. Wang X, et al. 2018. Mol Med Rep. 17:1660. PubMed
  147. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  148. Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed
  149. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  150. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  151. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  152. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  153. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  154. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  155. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  156. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  157. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  158. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  159. Xu X, et al. 2018. Cell. 175:1336. PubMed
  160. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  161. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  162. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  163. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  164. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  165. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  166. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  167. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  168. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  169. Koren E, et al. 2022. Nat Commun. 13:4628. PubMed
  170. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  171. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  172. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  173. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  174. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  175. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  176. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  177. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  178. Akhter N, et al. 2016. J Biol Chem. 291: 23672 - 23680. PubMed
  179. Huang B, et al. 2015. PLoS One. 10: 0134715. PubMed
  180. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  181. Sreekumar PG, et al. 2018. J Control Release. 283:94. PubMed
  182. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  183. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  184. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  185. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  186. Zheng L, et al. 2020. Front Oncol. 10:531131. PubMed
  187. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  188. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  189. França TT, et al. 2021. JCI Insight. 6:. PubMed
  190. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  191. Du J, et al. 2012. Stem Cells. 30:1447. PubMed
  192. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
  193. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  194. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  195. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  196. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  197. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  198. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  199. Port JR, et al. 2020. J Virol. 94:. PubMed
  200. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  201. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  202. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  203. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  204. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  205. Lingegowda H, et al. 2022. Front Reprod Health. 3:726936. PubMed
  206. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  207. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  208. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  209. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  210. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  211. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  212. Zhang W, et al. 2019. Mar Drugs. 0.845138889. PubMed
  213. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  214. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  215. Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed
  216. Scally S, et al. 2017. Nat Commun. . 10.1038/s41467-017-01924-3. PubMed
  217. Yi H, et al. 2021. Front Immunol. 12:719189. PubMed
  218. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  219. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  220. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  221. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  222. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  223. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  224. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  225. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  226. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  227. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  228. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  229. Cabrera-Perez J, et al. 2016. J Immunol. 197: 1692 - 1698. PubMed
  230. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  231. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  232. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  233. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  234. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  235. Smith-Díaz CC, et al. 2021. Front Oncol. 11:709543. PubMed
  236. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  237. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  238. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  239. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  240. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  241. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  242. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  243. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  244. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  245. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  246. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  247. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  248. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  249. Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed
  250. Campolo M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  251. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  252. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  253. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  254. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  255. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  256. Fujimoto M, et al. 2022. Nat Commun. 13:5408. PubMed
  257. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  258. Ravindran Menon D, et al. 2021. Pharmaceuticals (Basel). 14:. PubMed
  259. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  260. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  261. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  262. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  263. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  264. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  265. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  266. Tao Z, et al. 2022. Cells. 11:. PubMed
  267. Tang T, et al. 2022. J Immunother Cancer. 10:. PubMed
  268. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  269. Chen LH, et al. 2021. Sci Rep. 11:19478. PubMed
  270. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  271. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  272. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  273. Guo X, et al. 2020. J Cell Mol Med. . PubMed
  274. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  275. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  276. Pan X, et al. 2019. BMC Complement Altern Med. 19:163. PubMed
  277. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  278. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  279. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  280. Mincham KT, et al. 2021. Front Immunol. 11:601494. PubMed
  281. Zheng Y, et al. 2022. Transl Res. :. PubMed
  282. Gawish R, et al. 2022. Elife. 11:. PubMed
  283. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  284. Roberto MP, et al. 2021. Immunity. 54(8):1807-1824.e14. PubMed
  285. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  286. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  287. Tur J, et al. 2020. Cell Reports. 32(8):108079. PubMed
  288. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  289. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  290. Sun Q, et al. 2022. J Inflamm Res. 15:5827. PubMed
  291. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  292. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  293. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  294. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  295. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  296. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  297. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  298. Zuo S, et al. 2021. EBioMedicine. 64:103240. PubMed
  299. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  300. Li J, et al. 2021. eLife. 10:00. PubMed
  301. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  302. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  303. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  304. Martínez-Vicente P, et al. 2019. PLoS Pathog. 15:e1007658. PubMed
RRID
AB_312660 (BioLegend Cat. No. 100203)
AB_312661 (BioLegend Cat. No. 100204)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD3
Specificity Alt (DOES NOT SHOW ON TDS):
CD3
App Abbreviation (DOES NOT SHOW ON TDS):
FC
Hidden Names (DOES NOT SHOW ON TDS):
Naïve T Cell, T Follicular Helper, Th9, Th17, Th22
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
PE/Cyanine5 anti-mouse CD3 17A2
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
PerCP/Fire™ 780 anti-mouse CD3 Antibody 17A2 FC
PerCP anti-mouse CD3 Antibody 17A2 FC
Test 17A2 5 17A2
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account